Phase II Study in Fragile X Syndrome -- IND clearance received from FDA; first patient enrollment targeted by year-end with ...
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2025 Earnings Conference ...
Canada is one of the most popular study destinations for students around the world. It offers high-quality education, global exposure, and great career opportunities. But getting a Canadian study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results